1. Executive Summary
1.1 Advanced Wound Care: Market Review
1.2 Overview of Chapter Content
1.3 Research and Analysis Method
1.4 Glossary of Terms Relating to Advanced Wound Care
2. Introduction
2.1 What is a Wound?
2.1.1 Wound Classification
2.1.1.1 Acute Wounds
2.1.1.2 Chronic Wounds
2.1.1.2.1 The Increasing Prevalence of Chronic Wounds
2.1.1.3 Burns
2.2 The Skin
2.2.1 The Phases of Wound Healing
2.2.1.1 The Inflammatory Phase
2.2.1.2 The Proliferation Phase
2.2.1.3 The Fibroblastic Phase
2.2.1.4 The Maturation Phase
2.3 Wound Care
2.3.1 The Functions of Wound Care
2.3.2 The History of Wound Care
2.4 Wound Care Categories
2.4.1 Traditional Wound Care
2.4.2 Advanced Wound Care (AWC)
2.4.2.1 Moist Wound Care (MWC)
2.4.2.1.1 Alginate Dressings
2.4.2.1.2 Foam Dressings
2.4.2.1.3 Hydrocolloid Dressings
2.4.2.1.4 Hydrogel Dressings
2.4.2.2 Wound Care Devices
2.4.2.2.1 Negative Pressure Wound Therapy (NPWT)
2.4.2.2.2 Ultrasound for Wound Therapy
2.4.2.2.3 Electrical Stimulation
2.4.2.3 Biologics
2.4.2.3.1 Skin Replacement Therapies
2.4.2.3.2 Collagen Based Therapies
2.4.2.3.3 Cell Therapies
2.5 Regulation of Advanced Wound Care
2.5.1 The US Approval and Regulation System
2.5.2 The European Approval and Regulation Process
3. The Global Advanced Wound Care Market, 2010-2021
3.1 Advanced Wound Care: Market Overview
3.1.1 The Size of the Advanced Wound Care Market in 2010
3.2 Regional Market Breakdown, 2010
3.2.1 The US, European and Japanese Markets, 2010
3.2.2 The Chinese and Indian Market, 2010
3.3 Global Advanced Wound Care Market Forecast, 2011-2015
3.4 Global Advanced Wound Care Market Forecast, 2015-2021
3.5 Leading National Markets for Advanced Wound Care: Sales Forecasts, 2011-2021
3.5.1 The US, European and Japanese Markets, 2011-2021
3.5.1.1 The US Market
3.5.1.2 The European Market
3.5.1.3 The Japanese Market
3.5.2 The Chinese and Indian Markets, 2011-2021
3.5.2.1 The Chinese Market
3.5.2.2 The Indian Market
4. The Moist Wound Care Market, 2010-2021
4.1 The Moist Wound Care Market: Overview
4.1.1 The Moist Wound Care Market, 2010
4.1.2 Moist Wound Care Market Forecast, 2011-2021
4.2 The Moist Wound Care Market Segments, 2011-2021
4.2.1 The Hydrocolloid Dressings Market
4.2.2 The Foam Dressings Market
4.2.3 The Alginate Dressings Market
4.2.4 The Hydrogel Dressings Market
4.2.5 Other MWC Dressings Market
4.2.5.1 Hydrofiber Technology (ConvaTec)
4.3 The Moist Wound Care Pipeline
4.3.1 NanoDOX (Nanotherapeutics)
4.3.2 Novel Antimicrobial Silver Dressing (AGT Sciences Ltd)
4.3.3 '1' Primary Wound Dressing (Phytoceuticals)
4.4 SWOT Analysis of the Moist Wound Care Market, 2011-2021
4.4.1 Strengths
4.4.1.1 Established Segment of the Market
4.4.1.2 Wide Variety of Products
4.4.1.3 More Effective than Traditional Wound Care
4.4.2 Weaknesses
4.4.2.1 Less Effective than Some Devices and Biologics
4.4.2.2 Weak R&D Pipeline
4.4.3 Opportunities
4.4.3.1 Increasing Prevalence of Chronic Wounds
4.4.3.2 Cheap Alternative to Devices and Biologics
4.4.4 Threats
4.4.4.1 Emerging Technologies May be More Effective
4.4.4.2 Lack of R&D Spending Will Stifle Innovation
5. Wound Care Devices Market, 2010-2021
5.1 Wound Care Devices Market: Overview
5.1.1 The Wound Care Devices Market in 2010: Segment and Regional Breakdown
5.1.2 The Wound Care Devices Forecast, 2011-2021
5.2 The NPWT Market
5.2.1 The NPWT Market in 2010
5.2.2 Leading NPWT Devices: Product Analysis
5.2.2.1 V.A.C. Therapy (KCI)
5.2.2.1.1 V.A.C. Via (Kinetic Concepts Inc)
5.2.2.2 RENASYS Systems (Smith & Nephew)
5.2.2.3 Other NPWT Systems
5.2.2.3.1 POSiFECT (Biofisica)
5.3 The NPWT Market Forecast, 2011-2015
5.4 The NPWT Market Forecast, 2015-2021
5.5 The Wound Care Devices Pipeline
5.5.1 dermaPACE (Sanuwave Health)
5.5.2 O-ACE-Sys (Ingenious Technologies Corporation)
5.5.3 Red Light Wave Therapy (Lightwave Technologies)
5.5.4 MIST Therapy (Celleration)
5.6 SWOT Analysis of the Wound Care Devices Market, 2011-2021
5.6.1 Strengths
5.6.1.1 More Effective than Other Forms of Wound Care
5.6.1.2 Constant Innovation in the Market
5.6.2 Weaknesses
5.6.2.1 Dominated by Few Large Companies
5.6.2.2 NPWT Dominates the Market
5.6.3 Opportunities
5.6.3.1 Low Cost NPWT Systems will Drive Growth
5.6.3.2 Increasing Prevalence of Chronic Wounds
5.6.4 Threats
5.6.4.1 Controversy Regarding Safety of NPWT
5.6.4.2 Ongoing Legal Battles Threaten Innovation
6. The Wound Care Biologics Market, 2010-2021
6.1 Wound Care Biologics Market: Overview
6.1.1 Wound Care Biologics Market in 2010: Market Segments and Regional Breakdown
6.1.2 The Wound Care Biologics Market Forecast, 2011-2021
6.2 The Skin Replacement Market
6.2.1 The Skin Replacement Market in 2010
6.2.2 Leading Products in the Skin Replacement Market, 2010
6.2.2.1 Dermagraft (Advanced BioHealing, a Division of Shire Pharmaceuticals)
6.2.2.2 Apligraf (Organogenesis)
6.2.2.3 Other Leading Products
6.2.3 The Skin Replacement Market Forecast, 2011-2015
6.2.4 The Skin Replacement Market Forecast, 2015-2021
6.3 Collagen Based Therapy
6.3.1 Collagen Based Therapy Market in 2010
6.3.2 The Collagen Based Therapy Market Forecast, 2011-2015
6.3.3 The Collagen Based Therapy Market Forecast, 2015-2021
6.4 The Cell Therapy Market
6.4.1 The Cell Therapy Market in 2010
6.4.2 Leading Products in the Cell Therapy Market, 2010
6.4.3 The Cell Therapy Market Forecast, 2011-2015
6.4.4 The Cell Therapy Market Forecast, 2015-2021
6.5 The Biologics Pipeline
6.5.1 Stem Cells
6.5.1.1 Stem Cell Skin Gun (McGowan Institute for Regenerative Medicine at the University of Pittsburgh)
6.5.1.2 Adult Stem Cells (Cryo-Cell International and The Snyder Wound Research Institute)
6.5.1.3 Mesenchymal Stem Cells (Nara University, Japan)
6.5.2 Artificial Skin
6.5.2.1 e-Skin (UC Berkeley)
6.5.2.2 Genetically Modified Artificial Skin (University of Cincinnati)
6.5.3 Cell Therapy
6.5.3.1 ReCell (Avita Medical)
6.5.4 Automated Artificial Skin Production
6.5.4.1 The Tissue Factory (Fraunhofer Institute)
6.5.5 Nanotechnology
6.5.5.1 DermaFuse (Missouri S&T and Mo-Sci Corporation)
6.5.5.2 Phytochemical Tissue Bonding (Harvard University Institute of Photomedicine)
6.5.5.3 Giant Unilamellar Vesicles (University of Bath)
6.5.6 Collagen Based Therapy
6.5.6.1 Artificial Collagen Based Wound Care (Cornell University)
6.5.7 Diagnostic Tests
6.5.7.1 WOUNDCHEK (Systagenix Wound Management)
6.6 SWOT Analysis of the Wound Care Biologics Market, 2011-2021
6.6.1 Strengths
6.6.1.1 More Effective Than Other Forms of Wound Care
6.6.1.2 New Technology with Constant Innovation
6.6.1.3 Strong R&D Pipeline
6.6.2 Weaknesses
6.6.2.1 Small Start-up Companies Dominate the Market
6.6.2.2 Expensive Technology
6.6.2.3 High Barriers to Entry
6.6.3 Opportunities
6.6.3.1 Strong Innovation Will Drive Growth
6.6.3.2 Stem Cells Offer Multiple Opportunities
6.6.3.3 Increasing Prevalence of Chronic Wounds
6.6.4 Threats
6.6.4.1 Controversy Regarding the Effectiveness of Some Biologics
6.6.4.2 High Barriers to Entry will Deter Competitors
6.6.4.3 Competition from MWC and Devices
7. Advanced Wound Care Market: Analysis by Company, 2010
7.1 Smith & Nephew (S&N)
7.1.1 Smith & Nephew Advanced Wound Care Sales, 2010
7.1.2 Smith & Nephew Pipeline
7.2 Kinetic Concepts Inc (KCI)
7.2.1 KCI Advanced Wound Care Sales, 2010
7.2.2 KCI Pipeline
7.2.3 The Sale of KCI
7.3 ConvaTec
7.3.1 ConvaTec Sales, 2010
7.3.2 ConvaTec Advanced Wound Care Sales, 2010
7.3.3 ConvaTec Pipeline
7.4 Coloplast
7.4.1 Coloplast Sales, 2010
7.4.2 Coloplast Advanced Wound Care Sales, 2009/2010
7.5 Systagenix Wound Management
7.5.1 Systagenix Pipeline
8. Expert Opinions
8.1 Dr Edward Lin, CEO & Founder of Ingenious Technologies Corporation
8.1.1 The Wound Care Market
8.1.2 O-ACE-Sys Device Being Developed by Dr Lin
8.1.3 NPWT Devices
8.1.4 The Future of Wound Care Devices
8.2 Professor Kiminobu Sugaya, Professor of Neuroscience, Burnett School of Biomedical Science, University of Central Florida
8.2.1 The Current Stem Cell Field
8.2.2 Public Perception of Stem Cell Research
8.2.3 iPS cells and Wound Healing
9. Conclusions
9.1 The Advanced Wound Care Market, 2010-2021
9.1.1 Growth will be Driven by an Increasing Prevalence of Chronic Wounds
9.1.2 Emerging Markets will Drive Growth
9.2 The Moist Wound Care Market
9.3 The Wound Care Devices Market
9.4 The Wound Care Biologics Market
Appendix A
Appendix B - Visiongain report evaluation form
List of Tables
Table 2.1 The Rules of Nine: Percentage (%) of Total Body Classification System
Table 2.2 The Classification of Burns by Depth: Degree Classification System
Table 2.3 The Classification of Burns by Severity
Table 2.4 The Wound Care Market ($bn) by Sectors, 2010
Table 2.5 The Advantages and Disadvantages of Moist Wound Care
Table 2.6 The Benefits and Risks of Skin Grafting
Table 3.1 The Advanced Wound Care Market ($bn) by Segments, 2010
Table 3.2 Leading National Markets for Advanced Wound Care ($bn), 2010
Table 3.3 Global Advanced Wound Care Market Forecast ($bn), 2010-2015
Table 3.4 Global Advanced Wound Care Market Forecast ($bn), 2015-2021
Table 3.5 Leading Advanced Wound Care National Market Forecasts ($bn), 2010-2015
Table 3.6 Leading Advanced Wound Care National Market Forecasts ($bn), 2015-2021
Table 3.7 Chinese Advanced Wound Care Market: Drivers and Restraints, 2011-2021
Table 4.1 The Moist Wound Care Market ($bn) by Segments, 2010
Table 4.2 The Moist Wound Care Market ($bn) by Country/Region, 2010
Table 4.3 The Moist Wound Care Market Forecast ($bn), 2010-2015
Table 4.4 The Moist Wound Care Market Forecast ($bn), 2015-2021
Table 4.5 Moist Wound Care Products Pipeline, 2011
Table 4.6 SWOT Analysis of the Moist Wound Care Market, 2011-2021
Table 5.1 The Wound Care Device Market ($bn) by Segments, 2010
Table 5.2 The Wound Care Devices Market ($bn) by Country/Region, 2010
Table 5.3 The Wound Care Devices Market Forecast ($bn), 2010-2015
Table 5.4 The Wound Care Devices Market Forecast ($bn), 2015-2021
Table 5.5 Leading Products in the NPWT Market: Sales ($bn) and Market Share (%), 2010
Table 5.6 The NPWT Market Forecast ($bn), 2010-2015
Table 5.7 The NPWT Market Forecast ($bn), 2015-2021
Table 5.8 Drivers and Restraints in the NPWT Market, 2010-2021
Table 5.9 Wound Care Devices Development Pipeline, 2011
Table 5.10 SWOT Analysis of the Wound Care Devices Market, 2011-2021
Table 6.1 The Wound Care Biologics Market ($m) by Segments, 2010
Table 6.2 The Wound Care Biologics Market ($m) by Country/Region, 2010
Table 6.3 The Wound Care Biologics Market Forecast ($bn), 2010-2015
Table 6.4 The Wound Care Biologics Market Forecast ($bn), 2015-2021
Table 6.5 Drivers and Restraints in the Biologics Market, 2011-2021
Table 6.6 Dermagraft Sales ($m) 2007-2010
Table 6.7 Other Leading Products in the Skin Replacement Market, 2010
Table 6.8 The Skin Replacement Market Forecast ($bn), 2010-2015
Table 6.9 The Skin Replacement Market Forecast ($bn), 2015-2021
Table 6.10 Leading Products in the Collagen Based Therapy Market, 2010
Table 6.11 The Collagen Based Therapy Market Forecast ($bn), 2010-2015
Table 6.12 The Collagen Based Therapy Market Forecast ($bn), 2015-2021
Table 6.13 Leading Products in the Cell Therapy Market, 2010
Table 6.14 The Cell Therapy Market Forecast ($m), 2010-2015
Table 6.15 The Cell Therapy Market Forecast ($m), 2015-2021
Table 6.16 The Wound Care Biologics Development Pipeline, 2011
Table 6.17 SWOT Analysis of the Wound Care Biologics Market, 2011-2021
Table 7.1 Smith & Nephew Sales ($m) by Business Segments, 2010
Table 7.2 Smith & Nephew Sales ($m) by Region, 2010
Table 7.3 Smith & Nephew Advanced Wound Management Sales ($m) by Region, 2010
Table 7.4 KCI Total Revenue ($m) by Sales and Rentals, 2010
Table 7.5 KCI Total Sales ($m) by Business Segments, 2010
Table 7.6 KCI Active Healing Solutions (AHS) Sales ($m) by Region, 2010
Table 7.7 ConvaTec Sales ($m) by Business Segments, 2010
Table 7.8 ConvaTec Sales ($m) by Region, 2010
Table 7.9 Coloplast Sales ($bn) by Business Segments, 2009/2010
Table 7.10 Coloplast Sales ($bn) by Region, 2009/2010
Table 9.1 Global Advanced Wound Care Market: Drivers and Restraints, 2011-2021
List of Figures
Figure 2.1 The Phases of Wound Healing and Duration (Days)
Figure 2.2 Market Shares (%) of the Leading Sectors in the Wound Care Market, 2010
Figure 3.1 The Advanced Wound Care Market Share (%) by Segments, 2010
Figure 3.2 The Advanced Wound Care Market ($bn) by Segments, 2010
Figure 3.3 The Advanced Wound Care Market Share (%) in Leading National Markets, 2010
Figure 3.4 The Advanced Wound Care Market ($bn) in Leading National Markets, 2010
Figure 3.5 Global Advanced Wound Care Market Forecast ($bn), 2010-2015
Figure 3.6 Global Advanced Wound Care Market Forecast ($bn), 2015-2021
Figure 3.7 The US Advanced Wound Care Market Forecast ($bn), 2010-2015
Figure 3.8 The European Advanced Wound Care Market Forecast ($bn), 2010-2015
Figure 3.9 The Asian Advanced Wound Care Market Forecasts ($bn), 2010-2015
Figure 3.10 The US Advanced Wound Care Market Forecast ($bn), 2015-2021
Figure 3.11 The European Advanced Wound Care Market Forecast ($bn), 2015-2021
Figure 3.12 The Asian Advanced Wound Care Market Forecasts ($bn), 2015-2021
Figure 4.1 The Moist Wound Care Market Share (%) by Segments, 2010
Figure 4.2 The Moist Wound Care Market ($bn) by Segments, 2010
Figure 4.3 Moist Wound Care Market Shares (%) by Country/Region, 2010
Figure 4.4 Total Moist Wound Care Market Forecast ($bn), 2010-2015
Figure 4.5 Total Moist Wound Care Market Forecast ($bn), 2015-2021
Figure 5.1 The Wound Care Devices Market Share (%) by Segments, 2010
Figure 5.2 The Wound Care Devices Market ($bn) by Segments, 2010
Figure 5.3 The Wound Care Devices Market Share (%) by Country/Region, 2010
Figure 5.4 The Wound Care Devices Market Sales ($bn) by Country/Region, 2010
Figure 5.5 Total Wound Care Devices Market Forecast ($bn), 2010-2015
Figure 5.6 NPWT and Ultrasound Wound Therapy Devices Market Forecasts ($bn), 2010-2015
Figure 5.7 Total Wound Care Devices Market Forecast ($bn), 2015-2021
Figure 5.8 NPWT and Ultrasound Wound Therapy Devices Market Forecasts ($bn), 2015-2021
Figure 5.9 The NPWT Devices Market Share (%) by Leading Products, 2010
Figure 5.10 The NPWT Market Forecast ($bn), 2010-2015
Figure 5.11 The NPWT Market Forecast ($bn), 2015-2021
Figure 6.1 The Wound Care Biologics Market Share (%) by Segments, 2010
Figure 6.2 The Wound Care Biologics Market ($m) by Segments, 2010
Figure 6.3 The Wound Care Biologics Market Share (%) by Country/Region, 2010
Figure 6.4 The Wound Care Biologics Market Sales ($m) by Country/Region, 2010
Figure 6.5 The Biologics Market Forecast ($bn), 2010-2021
Figure 6.6 Dermagraft Sales ($m) 2007-2010
Figure 6.7 The Skin Replacement Market Forecast ($bn), 2010-2015
Figure 6.8 The Skin Replacement Market Forecast ($bn), 2015-2021
Figure 6.9 The Collagen Based Therapy Market Forecast ($bn), 2010-2015
Figure 6.10 The Collagen Based Therapy Market Forecast ($bn), 2015-2021
Figure 6.11 The Cell Therapy Market Forecast ($m), 2010-2015
Figure 6.12 The Cell Therapy Market Forecast ($bn), 2015-2021
Figure 7.1 Smith & Nephew Sales Share (%) by Business Segment, 2010
Figure 7.2 Smith & Nephew Sales ($m) by Business Segment, 2010
Figure 7.3 Smith & Nephew Sales Share (%) by Region, 2010
Figure 7.4 Smith & Nephew Sales ($m) by Region, 2010
Figure 7.5 Smith & Nephew Advanced Wound Management Sales Share (%) by Region, 2010
Figure 7.6 KCI Total Revenue Shares (%) by Sales and Rentals, 2010
Figure 7.7 KCI Total Sales Share (%) by Business Segments, 2010
Figure 7.8 KCI Total Sales ($m) by Business Segments, 2010
Figure 7.9 KCI Active Healing Solutions (AHS) Sales Share (%) by Region, 2010
Figure 7.10 ConvaTec Sales Share (%) by Business Segment, 2010
Figure 7.11 ConvaTec Sales ($m) by Business Segment, 2010
Figure 7.12 ConvaTec Sales Share (%) by Region, 2010
Figure 7.13 Coloplast Sales Share (%) by Business Segments, 2009/2010
Figure 7.14 Coloplast Sales ($bn) by Business Segments, 2009/2010
Figure 7.15 Coloplast Sales Share (%) by Region, 2009/2010